首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >ASPD: A prospective study of adequacy in Asian patients on long term, small volume, continuous ambulatory peritoneal dialysis.
【24h】

ASPD: A prospective study of adequacy in Asian patients on long term, small volume, continuous ambulatory peritoneal dialysis.

机译:ASPD:对亚洲患者进行长期,小剂量,持续性非卧床腹膜透析的充分性的前瞻性研究。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: The impact of small solute clearance on patient survival in continuous ambulatory peritoneal dialysis (CAPD) is not yet solidified. Previously, we demonstrated that CAPD using small volume (6 L) daily exchanges provides adequate dialysis for most Asian patients. METHODS: We conducted a prospective, long-term observational study to determine the optimal dialysis adequacy that may provide better patient survival for Asian patients who receive small-volume CAPD. We recruited 294 patients. The initial CAPD regime was 3 x 2-L exchanges daily. The same regime was maintained unless there was significant loss of ultrafiltration or fluid retention despite the use of hypertonic dialysate. RESULTS: Median study period was 38.9 (range 5 - 76.5) months, with 81% and 27% of patients remaining in the study at 24 and 48 months respectively. The overall survival rates at 2 and 4 years were 94.0% and 74.8% respectively. Our long-term data revealed that survival rate was related to Kt/V values. Survival rateswere significantly higher for patients with total Kt/V > 2.0 than for patients with Kt/V < 1.7 (p = 0.02). The former group had lower body mass index and higher residual renal function and peritoneal Kt/V than the Latter group. On analysis using Cox proportional hazards regression models, cardiovascular disease (CVD), lower urine volume, and higher body mass index were independent predictors of mortality. Patients with higher renal Kt/V had a significantly lower risk of mortality (RR = 0.018, p = 0.01) after adjusting for the effects of CVD and diabetes mellitus. CONCLUSION: Our data recommend that 1.7 be the minimal target for total Kt/V in patients on long-term CAPD. Patients with high body mass index, low residual urine volume, and significant CVD need close monitoring.
机译:背景:在持续的非卧床腹膜透析(CAPD)中,小的溶质清除率对患者生存的影响尚未得到证实。以前,我们证明了每天使用小剂量(6 L)交流的CAPD可为大多数亚洲患者提供足够的透析能力。方法:我们进行了一项前瞻性,长期的观察性研究,以确定最佳的透析充分性,可以为接受小剂量CAPD的亚洲患者提供更好的患者生存率。我们招募了294名患者。最初的CAPD方案是每天3次2-L交换。除非使用高渗透析液,否则除非存在明显的超滤损失或液体滞留,否则应维持相同的治疗方案。结果:研究中位时间为38.9(5-76.5)个月,分别有81%和27%的患者分别在24和48个月留在研究中。 2年和4年总生存率分别为94.0%和74.8%。我们的长期数据显示,存活率与Kt / V值相关。总Kt / V> 2.0的患者的生存率明显高于Kt / V <1.7的患者(p = 0.02)。前者的体重指数较低,残余肾功能和腹膜Kt / V高于后者。使用Cox比例风险回归模型进行分析时,心血管疾病(CVD),尿量减少和体重指数较高是死亡率的独立预测因子。调整CVD和糖尿病的影响后,肾Kt / V较高的患者的死亡风险显着降低(RR = 0.018,p = 0.01)。结论:我们的数据建议1.7为长期CAPD患者总Kt / V的最小目标。体重指数高,残留尿量少,CVD严重的患者需要密切监测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号